skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: ScienceDirect Journals remover Base de dados/Biblioteca: HighWire Press (Free Journals) remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1c
Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1c
Material Type:
Artigo 		Adicionar ao Meu Espaço

Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1c

Liang, Guosheng ; Yang, Jian ; Horton, Jay D. ; Hammer, Robert E. ; Goldstein, Joseph L. ; Brown, Michael S.

The Journal of biological chemistry, 2002-03, Vol.277 (11), p.9520-9528 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

Maloney, David G. ; Molina, Arthur J. ; Sahebi, Firoozeh ; Stockerl-Goldstein, Keith E. ; Sandmaier, Brenda M. ; Bensinger, William ; Storer, Barry ; Hegenbart, Ute ; Somlo, George ; Chauncey, Thomas ; Bruno, Benedetto ; Appelbaum, Frederick R. ; Blume, Karl G. ; Forman, Stephen J. ; McSweeney, Peter ; Storb, Rainer

Blood, 2003-11, Vol.102 (9), p.3447-3454 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Problem-solving therapy–induced amygdala engagement mediates lifestyle behavior change in obesity with comorbid depression: a randomized proof-of-mechanism trial
Problem-solving therapy–induced amygdala engagement mediates lifestyle behavior change in obesity with comorbid depression: a randomized proof-of-mechanism trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Problem-solving therapy–induced amygdala engagement mediates lifestyle behavior change in obesity with comorbid depression: a randomized proof-of-mechanism trial

Lv, Nan ; Lefferts, Wesley K ; Xiao, Lan ; Goldstein-Piekarski, Andrea N ; Wielgosz, Joseph ; Lavori, Philip W ; Simmons, Janine M ; Smyth, Joshua M ; Stetz, Patrick ; Venditti, Elizabeth M ; Lewis, Megan A ; Rosas, Lisa G ; Snowden, Mark B ; Ajilore, Olusola A ; Suppes, Trisha ; Williams, Leanne M ; Ma, Jun

The American journal of clinical nutrition, 2021-12, Vol.114 (6), p.2060-2073 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

Horwitz, Steven M. ; Negrin, Robert S. ; Blume, Karl G. ; Breslin, Sheila ; Stuart, Monic J. ; Stockerl-Goldstein, Keith E. ; Johnston, Laura J. ; Wong, Ruby M. ; Shizuru, Judith A. ; Horning, Sandra J.

Blood, 2004-02, Vol.103 (3), p.777-783 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease
Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease

Anderson, John P. ; Walker, Donald E. ; Goldstein, Jason M. ; de Laat, Rian ; Banducci, Kelly ; Caccavello, Russell J. ; Barbour, Robin ; Huang, Jiping ; Kling, Kristin ; Lee, Michael ; Diep, Linnea ; Keim, Pamela S. ; Shen, Xiaofeng ; Chataway, Tim ; Schlossmacher, Michael G. ; Seubert, Peter ; Schenk, Dale ; Sinha, Sukanto ; Gai, Wei Ping ; Chilcote, Tamie J.

The Journal of biological chemistry, 2006-10, Vol.281 (40), p.29739-29752 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition
A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition
Material Type:
Artigo 		Adicionar ao Meu Espaço

A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition

Horn, Isaac P. ; Marks, David L. ; Koenig, Amanda N. ; Hogenson, Tara L. ; Almada, Luciana L. ; Goldstein, Lauren E. ; Romecin Duran, Paola A. ; Vera, Renzo ; Vrabel, Anne M. ; Cui, Gaofeng ; Rabe, Kari G. ; Bamlet, William R. ; Mer, Georges ; Sicotte, Hugues ; Zhang, Cheng ; Li, Hu ; Petersen, Gloria M. ; Fernandez-Zapico, Martin E.

The Journal of biological chemistry, 2021-01, Vol.296, p.100634-100634, Article 100634 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans
Material Type:
Artigo 		Adicionar ao Meu Espaço

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

de Morais, S M ; Wilkinson, G R ; Blaisdell, J ; Nakamura, K ; Meyer, U A ; Goldstein, J A

The Journal of biological chemistry, 1994-06, Vol.269 (22), p.15419-15422 [Periódico revisado por pares]

United States: American Society for Biochemistry and Molecular Biology

Texto completo disponível

Citações Citado por
8
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)

Mead, Graham M. ; Barrans, Sharon L. ; Qian, Wendi ; Walewski, Jan ; Radford, John A. ; Wolf, Max ; Clawson, Simon M. ; Stenning, Sally P. ; Yule, Claire L. ; Jack, Andrew S.

Blood, 2008-09, Vol.112 (6), p.2248-2260 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Proton Block and Voltage Gating Are Potassium-dependent in the Cardiac Leak Channel Kcnk3
Proton Block and Voltage Gating Are Potassium-dependent in the Cardiac Leak Channel Kcnk3
Material Type:
Artigo 		Adicionar ao Meu Espaço

Proton Block and Voltage Gating Are Potassium-dependent in the Cardiac Leak Channel Kcnk3

Lopes, Coeli M.B. ; Gallagher, Patrick G. ; Buck, Marianne E. ; Butler, Margaret H. ; Goldstein, Steve A.N.

The Journal of biological chemistry, 2000-06, Vol.275 (22), p.16969-16978 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab

Tebbutt, N.C. ; Murphy, F. ; Zannino, D. ; Wilson, K. ; Cummins, M.M. ; Abdi, E. ; Strickland, A.H. ; Lowenthal, R.M. ; Marx, G. ; Karapetis, C. ; Shannon, J. ; Goldstein, D. ; Nayagam, S.S. ; Blum, R. ; Chantrill, L. ; Simes, R.J. ; Price, T.J.

Annals of oncology, 2011-08, Vol.22 (8), p.1834-1838 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.